| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9872073 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 5 Pages |
Abstract
Conclusions: In view of the significant locoregional control benefit, radiotherapy remains indicated in Stage I endometrial carcinoma patients with high-risk features for locoregional relapse.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Astrid N. M.D., Wim L.J. M.Sc., Henk M.D., Vincent T.H.B.M. M.D., Peter C.M. M.D., Marnix L.M. M.D., Jan J. M.D., Carla C. M.D., Karin A.J. M.D., Ludy C.H.W. M.D., Mat M.D., Carien L. M.D., PORTEC Study Group PORTEC Study Group,